<!--FOR COPYING articles.-->
<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]>      <html class="no-js"> <![endif]-->
<html lang="en">

<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <title>Nanotechnology in Medicine</title>
    <meta name="Nanotechnology in Medicine" content="Nanotechnology in Medicine">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no" />
    <link rel="stylesheet" href="../css/index.css">
    <link rel="stylesheet" href="../css/article.css">

    <link rel="icon" href="../white-on-clear.ico" type="image/x-icon">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
    <script src="../"></script>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.1.0/jquery.min.js"></script>

    <meta name="description" content="Nanotechnology in Medicine">
    <meta property="og:locale" content="en_VN">
    <meta property="og:site_name" content="The Science Times">
    <meta property="og:type" content="website">
    <meta property="og:title" content="Nanotechnology in Medicine">
    <meta property="og:description" content="Nanotechnology in Medicine by Zion Kim">
    <meta property="og:url" content="article_link">
    <meta property="og:site_name" content="The Science Times">
    <meta property="og:image" content="https://thesciencetimes.github.io/thesciencetimes/multiple/nano-zk/cover-nano.png">
    <meta property="og:image:alt" content="Cover for The Science Times Volume 1 Dec 2023">
    <meta property="og:image:width" content="1200">
    <meta property="og:image:width" content="630">
    <link rel="canonical" href="article_link">
    <!-- article author -->
    <link rel="author" href="../contributors/writers/jinseo_kim.html">

    <!-- Twitter Meta Tags -->
    <meta name="twitter:card" content="summary_large_image">
    <meta property="twitter:domain" content="sciencetimes.github.io">
    <meta property="twitter:url" content="article_link">
    <meta name="twitter:title" content="Nanotechnology in Medicine">
    <meta name="twitter:description" content="Nanotechnology in Medicine">
    <meta name="twitter:image" content="https://thesciencetimes.github.io/thesciencetimes/multiple/nano-zk/cover-nano.png">
    <!-- Meta Tags Generated via https://www.opengraph.xyz -->

</head> <!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-824CMKDDZM"></script>
<script>
    window.dataLayer = window.dataLayer || [];
    function gtag() { dataLayer.push(arguments); }
    gtag('js', new Date());

    gtag('config', 'G-824CMKDDZM');
</script>

<body>
    <!--start content.-->
    <header>
        <div class="header">
            <div class="headlogo">
                <div class="logo">
                    <a href="../index.html">
                        <img src="../logo.svg"></img>
                    </a>
                </div>
            </div>
            <div class="topnav" id="myTopnav">
                <a href="../index.html">Home</a>
                <a href="../biology.html">Biology</a>
                <a href="../physics.html">Physics</a>
                <a href="../chemistry.html">Chemistry</a>
                <a href="../math.html">Math</a>
                <a href="../tech.html">Tech</a>
                <a href="../others.html">Others</a>
                <a href="../issues.html">Issues</a>
                <a href="../fun.html">Fun</a>
                <a href="../about.html">About</a>
                <!-- CHECK FILE PATH BEFORE LOCKING IN -->
            </div>
        </div>
    </header>

    <main>
        <div class="article"> <!--min-width for this div-->
            <div class="article_out_contain">
                <div class="article_in_contain" id="container">
                    <div class="post_top">
                        <h1>Nanotechnology in Medicine</h1>
                        <a href="../contributors/writers/jinseo_kim.html">
                            <h3>Zion Kim</h3>
                        </a>
                        <p id="time">January 2024</p>
                        <!-- publication date -->
                        <hr>
                        <!--uppercase-->
                        <h3 id="lead-in" style="text-align: center; font-style: italic;">A push towards better health
                            care.
                        </h3>
                        <figure class="cover-image">
                            <img id="image" src="./nano-zk/cover-nano.png">
                        </figure>
                        <p id="lead-in">Nanotechnology, a discipline harnessing the power of the infinitesimally small,
                            has quietly
                            woven itself into the fabric of our society over the years. In this convergence of science
                            and innovation, nanotechnology emerges not just as a tool but as a beacon of promise for the
                            future of healthcare. Nanotechnology can be used in a variety of industries not limited to
                            but including, industrial, medical, and in the energy industry. The prefix “nano” signifies
                            its dimension, a world unseen by the naked eye. So how much were we leaving it on the table?
                            Well, it turns out that when its true potential is revealed, nanotechnology can be
                            remarkable, especially in the field of medicine. Here, its impact goes beyond incremental:
                            nanotechnology could revolutionize drug delivery, imaging, diagnostics, and treatment
                            effectiveness just to name a few. </p>
                    </div>
                    <!--main content.-->

                    <div class="content">
                        <section id="drug-delivery">
                            <h2 class="article_subhead">Drug Delivery Systems</h2>
                            <p>Traditionally, when patients are given drugs, there are many limitations such as low
                                bioavailability (requires a larger dose to reach the minimum effective concentration
                                threshold), pervasive side effects, and a lack of precision in targeting. In addition to
                                this issue is the often indiscriminate impact of drugs.</p>
                            <p>As they sweep through the body, the drugs fail to distinguish between healthy and
                                diseased cells, essentially wiping the whole area out. These limitations with
                                traditional drugs can be fixed with the help of nanotechnology. Liposomes and
                                nanoparticles are types of nanocarriers that are inventions of nanotechnology. These
                                nanocarriers encase the drugs, shielding them from premature degradation during their
                                long journey through bodily fluids to their target. The true power, however, lies in the
                                controlled release facilitated by these carriers, honing in on specific areas at the
                                nanoscale. This not only preserves the amount of drugs needed (the key component
                                responsible for the intended therapeutic outcome), helping when bioavailability is low,
                                but it also removes damage to the healthy cells and maximizes the efficacy of treatment.
                            </p>
                        </section>

                        <section id="imagine_things">
                            <h2 class="article_subhead">Imagining (MRI, PET, X-RAY, ETC)</h2>
                            <div id="danger" style="float: right; 
                            margin: 5px;">
                                <img id="Trash in water" src="./nano-zk/nano-1.png" style="width: 24vw; margin:5px">
                            </div>

                            <div>
                                <p>Despite current high technology imagining equipment such as magnetic resonance
                                    imaging (MRI) and positron emission tomography (PET), the quest for heightened
                                    resolution
                                    and early detection persists. Conventional MRIs and PET machines, while formidable
                                    in
                                    their capabilities, are lacking in many ways. One of such shortages is that they are
                                    not
                                    able to detect small infected parts, and sometimes the detected parts do not stand
                                    out
                                    from uninfected regions. Here is where nanotechnology comes in. Nano marvels emerge
                                    as
                                    catalysts, elevating the resolution of imaging modalities to unprecedented levels.
                                    These nano agents help these existing equipment to be used and enable healthcare
                                    professionals to detect the disease at their early stages. Moreover, nanoparticles,
                                    armed with
                                    imaging capabilities, help reveal the pathway of real-time location of the where the
                                    drug is
                                    taking effect, unraveling crucial insight into treatment efficacy. They are able to
                                    reveal the pathway of real-time drug delivery as it shows PET machines a strong
                                    signal. Quantum dots, for example, have the key property where it has the ability to
                                    fluorescence, emitting light when exposed to a particular wavelength. These
                                    emissions can be tunable meaning that both the size and brightness can be controlled
                                    to be
                                    detected by sensor receptions on the MRI and PET wavelength scans. While
                                    nanotechnology might not seem strong on itself, the fusion of it with existing
                                    medical imaging, a
                                    new frontier emerges-one that truly elevates healthcare to a new level.
                                </p>
                            </div>
                            <!--<img></img>-->
                        </section>

                        <section id="diagnostics">
                            <h2 class="article_subhead">Diagnostics</h2>
                            <div id="danger" style="
                            margin: 5px;">
                                <img id="Trash in water" src="./nano-zk/nano-2.jpg" style="width: 24vw; margin:5px">
                            </div>
                            <p style="text-align: justify;"> The very pinnacle of hospitals and the first step in curing patients, nanotechnology
                                emerges as a powerful tool for medical professionals to use. Nanotechnology can be
                                engineered to discern specific biomarkers indicative of diseases at their early stages,
                                where they are the most vulnerable.Nanotechnology will help medical professionals to
                                catch the symptoms before it is too late, potentially leading to deadly outcomes. For
                                example, cancer, considered to be the worst enemy of humankind, is curable during its
                                early stages, but becomes deadly once it goes unnoticed. Nanosensors–a type of
                                nanotechnology–can help by identifying cancerous cells or circulating tumor markers that
                                a normal diagnosis would not be able to do so. This is because nanosensors will attach
                                and alert PET scanners and show up as a special color. Not only that, due to the
                                biometrics that different types of symptoms give, each nanosensor could be specifically
                                engineered to test that specific type of cancer, allowing no errors in medical
                                prescriptions. Doctors and healthcare professionals know that in the case of cancer and
                                tumors, time is their worst enemy and would significantly benefit from this technology.
                                Nanotechnology in the medical field not only helps with early diagnoses which allows for
                                timely intervention but also arms professionals with vital information to prescribe
                                targeted treatments, elevating the odds of success and improving patient outcomes. This
                                technology can and will save countless lives. </p>

                        </section>

                        <section id="treatment_effective">
                            <h2 class="article_subhead">Treatment Effectiveness</h2>
                            <p>Not only is it an aid in the medical realm, nanotechnology itself could be the cure for
                                existing diseases. For example, gold and silver nanoparticles can be used for cancer
                                treatment through photothermal therapy. By selectively detecting cancer cells and then
                                using external stimuli such as laser light, these nanoparticles can induce localized
                                hyperthermia, destroying cancer cells in the process. This cancer treatment is very
                                effective as it removes all cancer cells while leaving no damage to any healthy cells in
                                that area. </p>
                            <p></p>
                            <p></p>
                            <p></p>
                        </section>
                        <section id="Conclusion">
                            <h2 class="article_subhead">Conclusion</h2>
                            <p>Nanotechnology has been the key to unlock new heightened pathways for the healthcare
                                industry. Offering unprecedented opportunities to enhance drug delivery systems,
                                imaging, diagnostics, and treatment. As researchers continue to unravel the potential of
                                nanotechnology, we can see the potential to integrate it into mainstream medical
                                practices. The ongoing collaboration between scientists, clinicians, and ethicists is
                                crucial to harness the full potential of nanotechnology in medicine while addressing
                                potential challenges and ethical considerations. The future of healthcare is intertwined
                                with the continued exploration and application of nanotechnology, saving lives and
                                improving the human race. </p>
                            <p>There are concerns as the technology is relatively new, that there would be toxicity of
                                certain nanoparticles, specifically in the long term. There were also considerations of
                                the environmental impact if they were in mass production and how medical professionals
                                would dispose of it. It is important to warn people about how there should always be a
                                balance between innovation and safety. As safety is another fundamental core of
                                healthcare. It seems that long term research should be conducted and more people should
                                be educated on this matter. </p>
                        </section>
                    </div>
                    <!--CITATION-->
                    <section id="references">
                        <div class="ref">
                            <h3><b>References</b></h3>
                            <p><a href="link1">Akhlesh K. Jain and Keerti Mishra (2022). “Nanoparticles and
                                    Nanocarriers- Based Pharmaceutical Formulations”. Bentham Science Publishers
                                    Pte.</a>
                            </p>
                            <p><a href="link2">"Nanotechnology - 2nd Edition". www.elsevier.com. Retrieved
                                    2021-04-09.</a>
                            </p>
                            <p><a href="link3">Torchilin VP, editor. Nanoparticulates as Drug Carriers. Imperial College
                                    Press; 2006.</a>
                            </p>
                            <p><a href="link4">Thassu D, Deleers M. In: Nanoparticulate Drug Delivery Systems. Pathak Y,
                                    editor. Informa Healthcare USA; 2007.</a>
                            </p>
                            <p><a href="link5">Ferrari M. Cancer nanotechnology: opportunities and challenges. Nature
                                    Rev. Cancer. 2005;5:161–171. - PubMed</a>
                            </p>
                            <p><a href="link6">van Vlerken LE, Amiji MM. Multi-functional polymeric nanoparticles for
                                    tumor-targeted drug delivery. Expert Opin. Drug Deliv. 2006;3:205–216. - PubMed</a>
                            </p>
                            <p><a href="link7">Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical
                                    nanocarriers. Eur. J. Pharm. Biopharm. 2009;71:431–444. - PMC - PubMed</a>
                            </p>
                            <p><a href="link8">Atchison, R. W., B. C. Casto, and W. M. Hammon. 1965.
                                    Adenovirus-associated defective virus particles. Science 194:754-756. - PubMed</a>
                            </p>
                            <p><a href="link9">Bandelt, H. J., and A. W. Dress. 1992. Split decomposition: a new and
                                    useful approach to phylogenetic analysis of distance data. Mol. Phylogenet. Evol.
                                    1:242-252. - PubMed
                                </a></p>
                            <p><a href=" link10">
                                    Bantel-Schaal, U., and H. Zur Hausen. 1984. Characterization of the DNA of a
                                    defective human parvovirus isolated from a genital site. Virology 134:52-63. -
                                    PubMed</a></p>
                            <p><a href="link11">
                                    Blacklow, N. R., M. D. Hoggan, and W. P. Rowe. 1967. Isolation of
                                    adenovirus-associated viruses from man. Proc. Natl. Acad. Sci. USA 58:1410-1415. -
                                    PMC - PubMed</a></p>
                            <p><a href="link9">Blacklow, N. R., M. D. Hoggan, and W. P. Rowe. 1968. Serologic evidence
                                    for human infection with adenovirus-associated viruses. J. Natl. Cancer Inst.
                                    40:319-327. - PubMed
                                </a></p>
                            <p><a href=" link10">
                                    https://www.spandidos-publications.com/10.3892/br.2021.1418</a></p>
                            <p><a href="link11">
                                    https://www.sciencedirect.com/science/article/pii/S2414644723000337</a></p>
                            <p><a href="link11">
                                    https://pubmed.ncbi.nlm.nih.gov/16456071/</a></p>
                        </div>
                    </section>
                </div>
                <section id="others">
                    <aside class="author">
                        <!-- add profile image, etc. -->
                    </aside>
                </section>
            </div>
        </div>
        <!--think about aside elements | other articles? to fill margins.-->
    </main>


 <footer>
        <span class="email-container">Email: <button class="email" onclick="copyEmail()">thesciencetimesmagazine@gmail.com</button><span class="popup">Copied!</span></span>
        <p>© The Science Times 2023-2024</p>
        <p class="socials">Visit us on these platforms... <a href="https://www.facebook.com/thesciencetimesmagazine/" class="fa fa-facebook"></a> <a href="https://www.instagram.com/the_science_times_/" class="fa fa-instagram"></a></p>            
    </footer>
    <script>
        const email = document.querySelector(".email");
        const popup = document.querySelector(".popup");
        let timer = 1;
        function copyEmail() {
            navigator.clipboard.writeText("thesciencetimesmagazine@gmail.com")
            popup.classList.remove('popup-gone');
            popup.classList.add('popup-show');
            let timeout1 = setInterval(() => {
                timer++
                if (timer >= 300) {
                    clearInterval(timeout1);
                    timer = 1;
                    popup.classList.remove('popup-show')
                    popup.classList.add('popup-gone')
                }
            }, 1);
        }
    </script>

</body>

</html>